Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146501
Max Phase: Preclinical
Molecular Formula: C30H40N6O2S
Molecular Weight: 548.76
Molecule Type: Small molecule
Associated Items:
ID: ALA2146501
Max Phase: Preclinical
Molecular Formula: C30H40N6O2S
Molecular Weight: 548.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN(CC[C@H]1CC[C@H](NC(=O)c2ccc(-c3noc(C4CC4)n3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
Standard InChI: InChI=1S/C30H40N6O2S/c1-2-16-36(24-13-14-25-26(18-24)39-30(31)33-25)17-15-19-3-11-23(12-4-19)32-28(37)21-7-5-20(6-8-21)27-34-29(38-35-27)22-9-10-22/h5-8,19,22-24H,2-4,9-18H2,1H3,(H2,31,33)(H,32,37)/t19-,23-,24-/m0/s1
Standard InChI Key: FDWPTQOUYYKTSV-IGKWTDBASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 548.76 | Molecular Weight (Monoisotopic): 548.2933 | AlogP: 5.60 | #Rotatable Bonds: 10 |
Polar Surface Area: 110.17 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 10.66 | CX LogP: 5.75 | CX LogD: 2.64 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.34 | Np Likeness Score: -1.63 |
1. Chen J, Levant B, Wang S.. (2012) High-affinity and selective dopamine D₃ receptor full agonists., 22 (17): [PMID:22871578] [10.1016/j.bmcl.2012.07.003] |
Source(1):